AI-powered platform automating regulatory document generation for pharma companies. Reduces submission prep time by 70% with real-time FDA/EMA compliance checks. Targets mid-sized pharma and biotechs with tiered SaaS pricing starting at €1,500/month.
MediScript AI transforms pharmaceutical compliance by automating complex regulatory document preparation. Using advanced NLP trained on medical regulations, it generates submission-ready INDs and NDAs while performing real-time gap analysis against global standards. Designed for oncology and rare disease innovators, this platform drastically reduces human error and accelerates drug approval timelines.
Core Functionality
Automated generation of regulatory documents (INDs/NDAs/CTDs) with version control and audit trails. Real-time compliance gap analysis against FDA/EMA frameworks using integrated rule engines. Secure document repository with change tracking and eTMF system integration.
Target User and Segment
Regulatory affairs teams in mid-sized pharma (50-500 employees) and biotech startups handling 5-20+ annual submissions. Primary focus: US/EU companies specializing in oncology and rare disease therapeutics. Secondary market: Clinical research organizations (CROs) managing multiple client submissions.
Recommended Tech Stack
- NLP Core: Fine-tuned BioBERT/Hugging Face Transformers
- Backend: Python/Django REST API with Celery
- Database: PostgreSQL + Elasticsearch
- Frontend: React.js with Draft.js editor
- Infrastructure: AWS HIPAA-compliant environment (EKS, S3)
- Compliance DB: FDA eCTD schema + EU Annex 1 rulesets
Estimated MVP Hours and Costs
| Component | Hours | Cost (€100/h) |
|---|---|---|
| Backend development | 400 | €40,000 |
| NLP model training | 250 | €25,000 |
| Compliance engine | 300 | €30,000 |
| Frontend interface | 200 | €20,000 |
| QA/Testing | 150 | €15,000 |
| Total | 1300 | €130,000 |
SWOT Analysis
| Strengths | Weaknesses |
|---|---|
|
|
| Opportunities | Threats |
|
|
First 1000 Customers Strategy
Acquisition Channels: LinkedIn targeted ads (€15k/mo), industry webinars (DIA/RAPS), freemium for startups, BIO International sponsorships
Cost Projections: €2,100 CAC with 3.2% trial conversion. €630k spend targets 300 paid conversions, leveraging referrals for remainder
Monetization
Business Model: Tiered SaaS subscriptions
Pricing: Startup (€1,500/mo for 5 submissions), Growth (€4,200/mo for 20), Enterprise (€8,000+ unlimited)
Break-even: €37,500 monthly costs covered by 25 Growth-tier clients by Month 14
Core Team: Regulatory SME (0.5 FTE), AI Engineer (1 FTE), Full-stack Dev (1 FTE), Compliance Auditor (0.3 FTE)
Market Positioning and Competitors
Market Size: €2.1B EU reg-tech market (12% CAGR)
Competitors: Veeva Vault (enterprise), PhlexGlobal (CROs), Lorenz Life Sciences
Differentiation: AI-first predictive gap detection
Strategy: Inside sales + consultant partnerships
Micro-niches: Cell/gene therapy startups, psychedelics research, EU MDR transitions